Prevention and control methicillin-resistant staphylococcus aureus (MRSA) national clinical guideline No. 2

Hdl Handle:
http://hdl.handle.net/10147/317577
Title:
Prevention and control methicillin-resistant staphylococcus aureus (MRSA) national clinical guideline No. 2
Authors:
National Clinical Effectiveness Committee (NCEC)
Citation:
National Clinical Effectiveness Committee Prevention and control methicillin-resistant staphylococcus aureus (MRSA) national clinical guideline No. 2 2013
Publisher:
National Clinical Effectiveness Committee (NCEC)
Issue Date:
Dec-2013
URI:
http://hdl.handle.net/10147/317577
Item Type:
Guideline
Language:
en
Description:
Staphylococcus aureus (S. aureus) commonly colonises the skin and nose. Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a strain of bacteria that has become resistant to the antibiotics commonly used to treat ordinary staphylococcal infections. In the right setting MRSA can cause severe and at times fatal infections such as bloodstream infection (BSI), infective endocarditis, pneumonia and skin and soft tissue infections (SSTI).
Keywords:
PATIENT SAFETY; QUALITY; CLINICAL GOVERNANCE
Local subject classification:
AUDIT; CLINICAL GUIDELINE

Full metadata record

DC FieldValue Language
dc.contributor.authorNational Clinical Effectiveness Committee (NCEC)en_GB
dc.date.accessioned2014-05-28T11:27:02Z-
dc.date.available2014-05-28T11:27:02Z-
dc.date.issued2013-12-
dc.identifier.citationNational Clinical Effectiveness Committee Prevention and control methicillin-resistant staphylococcus aureus (MRSA) national clinical guideline No. 2 2013en_GB
dc.identifier.urihttp://hdl.handle.net/10147/317577-
dc.descriptionStaphylococcus aureus (S. aureus) commonly colonises the skin and nose. Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a strain of bacteria that has become resistant to the antibiotics commonly used to treat ordinary staphylococcal infections. In the right setting MRSA can cause severe and at times fatal infections such as bloodstream infection (BSI), infective endocarditis, pneumonia and skin and soft tissue infections (SSTI).en_GB
dc.language.isoenen
dc.publisherNational Clinical Effectiveness Committee (NCEC)en_GB
dc.subjectPATIENT SAFETYen_GB
dc.subjectQUALITYen_GB
dc.subjectCLINICAL GOVERNANCEen_GB
dc.subject.otherAUDITen_GB
dc.subject.otherCLINICAL GUIDELINEen_GB
dc.titlePrevention and control methicillin-resistant staphylococcus aureus (MRSA) national clinical guideline No. 2en_GB
dc.typeGuidelineen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.